Cerebrospinal Fluid Protein Biomarkers for Alzheimer’s Disease
Summary: The introduction of acetylcholine esterase (AChE) inhibitors as a symptomatic treatment of Alzheimer’s disease (AD) has made patients seek medical advice at an earlier stage of the disease. This has highlighted the importance of diagnostic markers for early AD. However, there is no clinical...
Gorde:
| Argitaratua izan da: | NeuroRx |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Am. Soc. for Experimental NeuroTherapeutics
2004
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC534929/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15717022/ https://ncbi.nlm.nih.govhttps://doi.org/10.1602/neurorx.1.2.213 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|